Post-doctoral researcher Tal Danino featured at the Galeria Nara Roesler in São Paulo, Brazil, for his work alongside artist Vik Muniz. A conversation between Vik, Tal, and the Galeria is described in this Koch Institute News Feature. Another article on The Creators Project describes the artistic collaboration.
Check out a video about the project, too!

You can find more information on Tal's website.

Model of viral lifecycle could help in finding a cure for hepatitis B: research from the lab featured by the MIT News Office

Image courtesy of the Centers for Disease Control and Prevention

State of the Art Review from Bhatia and colleagues featured on the cover of Science Translational Medicine: 'Cell and tissue engineering for liver disease'

Progress towards building artificial livers featured on NPR's 'Here and Now'

Bhatia named among the 100 Most Creative People in Business by Fast Company

Boston Globe features LMRT's low cost urine test for cancer in their Magazine.

Bhatia lab trainee, Alex Bagley, highlighted at Koch Institute image awards

Latest advance in our synthetic biomarker platform achives cancer detection by paper test

Featured on the MIT home page and covered widely in:

Collaboration with Manalis lab (Olcum et al, PNAS) highlights attogram scale measurements

Sangeeta Bhatia recruited to join the Ludwig Center for Molecular Oncology

TomoNews US animates recent publication on nanoparticle detection of thrombosis (Lin et al.)

Technology Review features Lin et al Thrombosis diagnostic

Sangeeta Bhatia named one of three Merkin Fellows by the Broad Institute of MIT and Harvard

March et. al. MPCC platform for human Malaria (CHM, 2013) makes Top 10 list in Malaria Nexus

Sangeeta Bhatia selected as one of '10 most influential women in biotech'

Our game NanoDoc to crowdsource nanomedicine attracts wide media attention

Featured on:

Synthetic Biomarker platform (NBT, 2012; ACS Nano, 2013; PNAS, 2014) awarded catalyst translation grant from the Deshpande Center for Technological Innovation

March et. al. MPCC platform for human Malaria (CHM, 2013) featured in Malaria Nexus

Synthetic biomarker platform (Kwong et al, NBT 2012) also detects blood clots
Featured on MIT home page and covered widely in: Also featured on the ACS Nano journal homepage:

Sangeeta Bhatia profiled at the Broad Institute via the 'Five Questions' interview format

Hepregen launches new human MPCC-based products for drug screening

Collaboration with the Broad Institute uncovers small molecules that expand and mature human liver cells

Featured on the MIT home page and also by: Coverage includes commentary on Stevens et al, in Nature Communications

Gates Foundation-funded work on In Vitro platform for Human Malaria research (March et al., 2013) widely touted
Press coverage includes:

Postdoc Sabine Hauert featured in Nature blog at the Lindau Nobel conference

Profile of Sangeeta Bhatia in "The Scientist"
When molecular biology methods failed her, Sangeeta Bhatia turned to engineering and microfabrication to build a liver from scratch.

Science without borders: Becoming cross-disciplinary

Grant to fund nanotech therapies for traumatic brain injuries
MIT's Sangeeta Bhatia is part of the research team funded by the $6 million DARPA grant.

InVERT molding paper featured on Nature Communications homepage

Nanoparticles amplify tumor signals, as covered in:

Bhatia lab contributions highlighted following launch of MIT's new 'Institute for Medical Engineering and Science'

Science and Science Translational Medicine have collaborated to publish a special feature on 'Biomaterials'. The package includes a Commentary article that combines short essays from invited Thought Leaders in the field - including Sangeeta Bhatia.

Check out our new videos that depict "Nanoparticle Transport in Tumors" with public-friendly language and graphics!

Nature Materials, now 10 years old, selected our paper (Park et. al., 2009) as one of their 20 "Landmark Articles."

How cancer cells break free from tumors, as covered in:

Most emailed article on

siRNA Nanoparticles Validate Cancer Targets, as covered in:

MIT spotlight: Nanoparticles show potential to shrink tumors

Chen/Bhatia lab collaboration: 3D-printed sugar network to help grown artificial liver
See coverage in:

Huffington Post UK highlights our 2012 Wellcome Image Award

Our progress in liver tissue engineering featured in context with a new unpublished advance

MIT’s 2012 IdeaStream Symposium allowed some of MIT’s brightest innovators to connect with a host of entrepreneurs and leaders in the business community. See GABE KWONG discuss what technological developments could be hitting the market someday on Greater Boston on WGBH.

More coverage of HEALs
‘Humanized mice with ectopic artificial liver tissues’ (Chen et al., 2011) has been recently featured by Kamiya & Miyajima, (2012) Hepatology, Volume 55, Issue 3

Wood et al. have created a microfluidic device that can measure decreased flow velocity in blood samples from patients with sickle cell disease.
Also covered in:

Sangeeta Bhatia gives 2 seminars on Engineering Tissue Replacements and and Microscale Liver Tissue Engineering, through iBioSeminars:

NextGen Voices
Congratulations to Vyas Ramanan and Andrew Warren who had their essays selected for online publication in Science NextGEN Voices:

Stem cells could drive hepatitis research forward
Scientists establish HCV infection in liver-like cells derived from iPSCs (pdf)
Featured in:

Changing the World
Eighteen Indian Scientists Who Are Changing the World: Forbes India, 2012

Particle physic
Taking advantage of a natural signalling system enables nanoparticles to deliver cancer drugs far more accurately

MIT Spotlight: Recreating human livers, in mice

NOVA Profile: Sangeeta Bhatia
Intrigued by the idea of artificial organs, a biomedical engineer uses computer-chip technology to craft tiny livers.

Inside the Lab
Learn more about the work the Bhatia lab is doing to use micro and nanotechnologies to improve the effectiveness of chemotherapy.

Artificial liver tissue predicts drug safety
Bhatia’s labo hs developed artificial human liver tissue that can be implanted in mice.

Recreating human livers, in mice
‘Humanized’ mice could help scientists study the side effects of new drugs before they reach clinical trials.

Mice with human livers deal with drugs the human way
'Humanized' mice could provide better assessment of drugs' toxicity for humans.

Nanoparticles communicate with each other inside the body to target tumors
Researchers from the LMRT and other labs have designed a new type of delivery system that dispenses cancer drugs.

Nanomedicine: Swarming towards the target
A system comprising 'signalling' and 'receiving' modules improves the targeting effect of a nanomedicine.

Nanoparticles hit tumours with one-two punch
Using scout particles to pave the way makes drug delivery more effective.

MIT Spotlight: Working in harmony
MIT-designed nanoparticles communicate with each other inside the body to target tumors more efficiently.

Koch Institute Research: Nanoparticles that Talk to One Other
Former Bhatia lab graduate student Geoff von Maltzahn discusses a new system that allows nanoparticles to communicate for more efficient cancer targeting.

Tissue models: A living system on a chip
Devices that combine cells and nanotechnology to reconstruct tissues and organs are now edging from cool concept to practical application.

Student inventor Alice Chen receives Lemelson-MIT Student Prize
$30,000 prizes awarded to inventive students nationwide; four leading universities celebrate 2011 winners

WBUR interview: Local Student Wins Prize For "Humanized" Mouse

Engineering a new way to study hepatitis C
Tissue engineers have successfully infected liver cells in the laboratory, allowing a better way to test new drugs.

Lab-grown Liver Cells Provide Model for Hepatitis C Infection
HHMI researchers and colleagues have developed a new method for growing human liver cells outside the body.

Hepatitis fight aided by liver cells advance
Scientists looking for a treatment for a dangerous liver virus have found new ways to study it in the laboratory.

Researchers develop 'nano cocktail' to target and kill tumors
Researchers at the LMRT have developed a "cocktail" of different nanometer-sized particles that locate, adhere to, and kill cancerous tumors.

Three MIT students are Rhodes Scholars
Steven Mo, 21, conducted more than 2,400 hours of research in Professor Sangeeta Bhatia’s laboratory, where he researched regenerative technologies.

Lemelson-MIT Student Prize Winner Presentation - Geoffrey von Maltzahn

Nature Materials News and Views
Nanoantennas heat up

Forbes 2009
Living Livers

Davos 2009 IdeasLab - Sangeeta Bhatia

FOX News
"Nanoworm" interview with Geoff von Maltzahn

Boston Globe
Her studies link engineering, biology

Technology Review

A Better Toxicity Test

Why small is beautiful in Electrical Engineering and Computer Science (pdf)

The Scientist
Sangeeta Bhatia Looks at Life's Architecture

Nanotechnology Now
Sangeeta Bhatia of MIT Pioneers Key Biomedical Advances

Sangeeta Bhatia of MIT Pioneers Key Biomedical Advances

MIT News
Team develops nanoparticles to battle cancer

MIT News
'Micro' livers could aid drug screening

MIT News
Remote-control nanoparticles deliver drugs directly into tumors

MIT News
HST device draws cells close--but not too close--together

MIT News
MIT nanoparticles may help detect, treat tumors

MIT News
MIT method allows 3-D study of cell tissue organization